The next frontier for prevention of heart and vascular disease isn't targeting lipids. It's about blocking inflammation. These are some of the ongoing clinical trials @NatureMedicine
https://t.co/DSLMoPFqs7
In a randomized phase 2 trial in patients with acute #coronary syndrome and high levels of the inflammation #biomarker CRP, treatment with low-dose interleukin-2 increased the numbers of regulatory T cells and reduced arterial #inflammation, as compared to placebo.
https://t.co/ceDIa0cDay
Dr Pauls @mathildepauls provided an update on managing acute stroke including presentation modes, methods of assessment, and up-to-date pharmacotherapies and interventions @Cambridge_Uni@CUH_NHS
Managing acute kidney injury and hyperkalemia expertly in secondary care - Dr Andy Fry @AndyFry101 going through a step by step approach in expertly managing this important emergency
@Cambridge_Uni@CUH_NHS
Dr Lisa Sharkey @lisa_shark going through a fantastic update of endoscopic techniques to treat multiple GI conditions from clips to sleeves and numerous pharmacotherapeutic advances in the gastro world
@Cambridge_Uni@CUH_NHS
Dr Ravi Mahadeva provided a thorough review of COPD in 2023, reminiscing the changes since the first CMS he presented at 16 years ago! @Cambridge_Uni@CUH_NHS